AbbVie (ABBV) Dividends Paid - Common (2013 - 2026)

AbbVie (ABBV) reported Dividends Paid - Common of $3.1 billion for Q1 2026, up 5.5% year-over-year from $2.9 billion in Q1 2025, and up 6.01% quarter-over-quarter from $2.9 billion in Q4 2025.

AbbVie (ABBV) Dividends Paid - Common (2013 - 2026) Analysis & Trends

AbbVie (ABBV) has 14 years of Dividends Paid - Common data on file, last reported at $3.1 billion in Q1 2026.

  • Dividends Paid - Common for Q1 2026 came in at $3.1 billion, up 5.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.8 billion (up 5.73% YoY), and the FY2025 annual result was $11.7 billion, up 5.73% from the prior year.
  • Dividends Paid - Common climbed to $3.1 billion in Q1 2026 per ABBV's latest filing, from $2.9 billion in the prior quarter.
  • Over five years, Dividends Paid - Common peaked at $3.1 billion in Q1 2026 and troughed at $2.5 billion in Q3 2022.
  • A 5-year average of $2.7 billion and a median of $2.8 billion in 2024 frame the typical range for Dividends Paid - Common.
  • The sharpest annual moves came in 2022 and 2024: Dividends Paid - Common gained 8.79% in 2022, then rose 4.17% in 2024.
  • A 5-year view of Dividends Paid - Common shows it stood at $2.5 billion in 2022, then increased by 4.79% to $2.6 billion in 2023, then rose by 4.8% to $2.8 billion in 2024, then grew by 5.78% to $2.9 billion in 2025, then rose by 6.01% to $3.1 billion in 2026.
  • Business Quant data shows ABBV's Dividends Paid - Common at $3.1 billion in Q1 2026, $2.9 billion in Q4 2025, and $2.9 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn -866.88 Mn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 1.55 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 3.13 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 3.09 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn 2.11 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 1.36 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 1.04 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 2.45 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 1.28 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 3.09 Bn
Mar 31, 2026 3.09 Bn
Dec 31, 2025 2.91 Bn
Dec 31, 2025 2.91 Bn
Sep 30, 2025 2.91 Bn
Sep 30, 2025 2.91 Bn
Jun 30, 2025 2.91 Bn
Jun 30, 2025 2.91 Bn
Mar 31, 2025 2.93 Bn
Mar 31, 2025 2.93 Bn
Dec 31, 2024 2.75 Bn
Dec 31, 2024 2.75 Bn
Sep 30, 2024 2.75 Bn
Sep 30, 2024 2.75 Bn
Jun 30, 2024 2.75 Bn
Jun 30, 2024 2.75 Bn
Mar 31, 2024 2.77 Bn
Mar 31, 2024 2.77 Bn
Dec 31, 2023 2.63 Bn
Dec 31, 2023 2.63 Bn